Jeffrey Borgia to Xenograft Model Antitumor Assays
This is a "connection" page, showing publications Jeffrey Borgia has written about Xenograft Model Antitumor Assays.
Connection Strength
0.075
-
Endothelin-1-Mediated Drug Resistance in EGFR-Mutant Non-Small Cell Lung Carcinoma. Cancer Res. 2020 10 01; 80(19):4224-4232.
Score: 0.045
-
PRMT1 Is a Novel Regulator of Epithelial-Mesenchymal-Transition in Non-small Cell Lung Cancer. J Biol Chem. 2015 May 22; 290(21):13479-89.
Score: 0.031